Cargando…

Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease

OBJECTIVES: Inflammatory bowel diseases (IBD), comprised of Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by a complex pathophysiology that is thought to result from an aberrant immune response to a dysbiotic luminal microbiota in genetically susceptible individuals. New techno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moustafa, Ahmed, Li, Weizhong, Anderson, Ericka L, Wong, Emily H M, Dulai, Parambir S, Sandborn, William J, Biggs, William, Yooseph, Shibu, Jones, Marcus B, Venter, J Craig, Nelson, Karen E, Chang, John T, Telenti, Amalio, Boland, Brigid S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795019/ https://www.ncbi.nlm.nih.gov/pubmed/29345635 http://dx.doi.org/10.1038/ctg.2017.58

Ejemplares similares

A robust ambient temperature collection and stabilization strategy: Enabling worldwide functional studies of the human microbiome
por: Anderson, Ericka L., et al.
Publicado: (2016)

Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies
por: Dulai, Parambir S., et al.
Publicado: (2019)

Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020)

Systematic review: Safety of balloon assisted enteroscopy in Crohn’s disease
por: Arulanandan, Ahilan, et al.
Publicado: (2016)

Microbial metagenome of urinary tract infection
por: Moustafa, Ahmed, et al.
Publicado: (2018)

Linking Inflammatory Bowel Disease Symptoms to Changes in the Gut Microbiome Structure and Function
por: Hassouneh, Sayf Al-Deen, et al.
Publicado: (2021)

Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
por: Fang, Xin, et al.
Publicado: (2020)

The blood DNA virome in 8,000 humans
por: Moustafa, Ahmed, et al.
Publicado: (2017)

Utilization of defined microbial communities enables effective evaluation of meta-genomic assemblies
por: Greenwald, William W., et al.
Publicado: (2017)

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease
por: Holmer, Ariela K., et al.
Publicado: (2020)

Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines
por: Zhou, Yanlin, et al.
Publicado: (2022)

Gene identification and protein classification in microbial metagenomic sequence data via incremental clustering
por: Yooseph, Shibu, et al.
Publicado: (2008)

Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis
por: Sandborn, William J, et al.
Publicado: (2019)

Tu1552: PRESERVED SARS-COV-2 VACCINE CELL-MEDIATED IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNEMODULATING THERAPIES
por: Boland, Brigid S., et al.
Publicado: (2022)

Analyses of the Microbial Diversity across the Human Microbiome
por: Li, Kelvin, et al.
Publicado: (2012)

Bacterial associations in the healthy human gut microbiome across populations
por: Loftus, Mark, et al.
Publicado: (2021)

Bacterial community structure alterations within the colorectal cancer gut microbiome
por: Loftus, Mark, et al.
Publicado: (2021)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2018)

Brains Vs Bowels
por: Pratt, Ben. H.
Publicado: (1875)

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome
por: Acosta, Andrés, et al.
Publicado: (2016)

Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies
por: Boland, Brigid S., et al.
Publicado: (2022)

Mucosal microbiome dysbiosis in gastric carcinogenesis
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2018)

Development of Inflammatory Bowel Disease in HIV Patients: A Danish Cohort Study (1983–2018) With American Validation (1999–2018)
por: Elmahdi, Rahma, et al.
Publicado: (2022)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

HIV-1 host interactions: integration of large-scale datasets
por: Telenti, Amalio
Publicado: (2009)

Host genome influences on susceptibility to HIV-1
por: Telenti, Amalio
Publicado: (2009)

Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease
por: Sauceda, Consuelo, et al.
Publicado: (2022)

Microbiome Analysis of Stool Samples from African Americans with Colon Polyps
por: Brim, Hassan, et al.
Publicado: (2013)

Functional characterization of 3D protein structures informed by human genetic diversity
por: Hicks, Michael, et al.
Publicado: (2019)

How Good is Stratification and Prediction Model Analysis Between Primary and Revisional Roux-en-Y Gastric Bypass Surgery? A Multi-center Study and Narrative Review
por: Hany, Mohamed, et al.
Publicado: (2023)

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis
por: Dulai, Parambir S., et al.
Publicado: (2020)

Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach
por: Serrano-Gómez, Gerard, et al.
Publicado: (2021)

The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease
por: Abdelbary, Mohamed M. H., et al.
Publicado: (2022)

A Case Study for Large-Scale Human Microbiome Analysis Using JCVI’s Metagenomics Reports (METAREP)
por: Goll, Johannes, et al.
Publicado: (2012)

Uncovering complex microbiome activities via metatranscriptomics during 24 hours of oral biofilm assembly and maturation
por: Edlund, Anna, et al.
Publicado: (2018)

Dysbiosis of the microbiome in gastric carcinogenesis
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2017)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn’s Disease
por: Dulai, Parambir S, et al.
Publicado: (2022)

SPA: a short peptide assembler for metagenomic data
por: Yang, Youngik, et al.
Publicado: (2013)

Learning a mixture of microbial networks using minorization–maximization
por: Tavakoli, Sahar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uta0r3vbgs5madpgqbonoe8vpj